Does Semaglutide Cause Muscle Loss — and Can You Prevent It?

Does wegovy actually eat into muscle, or is it mostly fat?

The short answer: semaglutide shifts the scales heavily towards fat loss, but lean mass does fall to some degree. In the STEP 1 trial, published in the New England Journal of Medicine, participants taking semaglutide 2.4mg lost an average of around 15% of body weight over 68 weeks. Body composition sub-studies from the STEP programme showed that fat mass accounted for roughly two-thirds to three-quarters of that total loss, with lean mass making up the remainder.

That ratio is actually broadly comparable to other methods of significant calorie restriction. The body does not distinguish perfectly between fat and muscle when energy intake falls sharply. What semaglutide does is reduce appetite substantially, which can deepen the calorie deficit faster than people expect. A deeper deficit, sustained over months, raises the risk that the body draws more on protein stores in muscle.

So the concern is real, but it is not unique to semaglutide. It is a feature of meaningful weight loss in general. The medicine itself does not appear to directly attack muscle tissue; the effect is indirect, through reduced energy and, often, reduced food intake that can make protein targets harder to hit. Knowing what to eat while on semaglutide becomes particularly relevant here, since the right food choices can meaningfully reduce the indirect pressure on lean tissue. Understanding what to eat on semaglutide becomes particularly relevant here.

Why does protein intake matter so much on GLP-1 treatment?

Protein is the primary dietary signal that tells your body to preserve muscle during a deficit. When calories fall but protein stays adequate, muscle breakdown slows. When both calories and protein fall together, as can happen when semaglutide suppresses appetite across the board, the body has less reason to protect lean tissue.

Most nutrition guidelines suggest adults aiming to preserve muscle during weight loss need somewhere between 1.2 and 1.6 grams of protein per kilogram of body weight per day. That is meaningfully above the general population average. On semaglutide, hitting even ordinary protein targets can feel difficult during the early weeks of treatment, when nausea and early fullness are common. A practical approach some people find useful: prioritising protein at the start of each meal, before hunger drops off further.

Thinking about meal ideas that work on semaglutide is not just about making eating tolerable; it is directly relevant to how much muscle you carry through to the other side of treatment. Liquid protein sources, eggs, Greek yoghurt, and fish tend to be easier to manage when appetite is low. Planning meals with protein first is worth building into your routine early, the same way some people keep their pen in the fridge door as a daily prompt that the whole treatment plan, not just the injection, needs consistency.

Does resistance exercise actually protect muscle on semaglutide?

Yes, and the evidence for this is consistent. Resistance exercise, meaning weight training, bodyweight work, or similar load-bearing activity, is one of the most reliable signals for muscle maintenance and growth. It works independently of diet and acts alongside adequate protein intake.

A study published in The BMJ examining exercise alongside GLP-1 therapy found that participants who incorporated structured resistance training preserved significantly more lean mass than those who did not, despite similar levels of total weight loss. The message is consistent with wider exercise science: the body holds onto muscle when it is regularly asked to use it.

This is worth factoring in from the start of treatment rather than treating it as something to add later. Even two sessions per week of resistance work shows benefit. Cardio activity is valuable for cardiovascular health but is less effective specifically for muscle preservation during calorie restriction. The NHS guidance on healthy weight recommends combining reduced calorie intake with increased physical activity, including strength work, for exactly this reason.

If you are not currently doing any resistance training and feel uncertain where to start, that is a question worth raising in your consultation. A prescriber can also flag whether your current health picture changes any exercise recommendations. For a fuller picture of how to structure eating alongside treatment, the foods to limit on semaglutide is useful background reading.

Should the risk of muscle loss change your decision about starting treatment?

For most people considering semaglutide for weight management, the answer is no, not in isolation. The health benefits of meaningful fat loss, including reductions in blood pressure, cholesterol, blood sugar, and cardiovascular risk, are well established. The partial loss of lean mass is a recognised trade-off, not a reason to avoid treatment, provided you approach nutrition and activity actively rather than passively.

The risk becomes more relevant in specific groups: older adults, people with already low muscle mass, or anyone with a condition affecting mobility or protein metabolism. A prescriber assessing your full clinical picture can weigh these factors properly. It is one reason why clinical review matters before, and during, treatment. If you want to explore how semaglutide works and what treatment involves, the Wegovy overview covers the broader picture, and our free consultation is the place to raise these questions with a prescriber directly.

One thing worth noting: appetite suppression on semaglutide sometimes leads people to eat too little overall, not just less fat. Undereating severely accelerates lean mass loss. If food feels unmanageable or hunger disappears almost entirely, that is a signal to raise with your prescriber, not to push through quietly. The question of hunger on semaglutide is something our team hears regularly.